Patent ID: 7749505
Filing Date: 2010-07-06
Classification: A61K,A61P,C07K,C12N,C12Q,G01N

Abstract:
1. A method for the treatment of a lung cancer in a patient, wherein the lung cancer is characterized by overexpression of the polypeptide provided in SEQ ID NO:176 or a variant of SEQ ID NO:176 having at least 95% identity to the amino acid sequence of SEQ ID NO:176, comprising administering to the patient a polypeptide comprising the amino acid sequence selected from the group consisting of: a. the amino acid sequence set forth in SEQ ID NO:176; b. the amino acid sequence of a variant of SEQ ID NO:176 having at least 95% identity to the amino acid sequence of SEQ ID NO:176; and c. the amino acid sequence of an immunogenic portion of the amino acid sequence of (a) or (b).